STOCK TITAN

[Form 4] Aehr Test Systems Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 overview – Aehr Test Systems (AEHR)

On 07/02/2025, Executive Vice President Alberto Salamone reported the acquisition of 6,609 shares of common stock via a restricted stock unit (RSU) grant recorded at $0 cost. After the award, his direct beneficial ownership rose to 62,850 shares, a total that includes unvested RSUs.

The explanatory note states that one-sixteenth of the RSU award vests every three calendar months, provided employment is maintained. No sales or derivative transactions were disclosed, and Table II shows no option activity. The filing therefore reflects routine equity compensation, not an open-market transaction, and does not by itself signal a directional view on AEHR’s valuation.

Panoramica del Modulo 4 – Aehr Test Systems (AEHR)

Il 07/02/2025, il Vice Presidente Esecutivo Alberto Salamone ha comunicato l’acquisto di 6.609 azioni ordinarie tramite una concessione di unità azionarie vincolate (RSU) registrata a costo $0. Dopo l’assegnazione, la sua posizione diretta di proprietà beneficiaria è salita a 62.850 azioni, un totale che include anche le RSU non ancora maturate.

La nota esplicativa specifica che un sedicesimo delle RSU assegnate matura ogni tre mesi solari, a condizione che il rapporto di lavoro venga mantenuto. Non sono state dichiarate vendite o operazioni su derivati, e la Tabella II non evidenzia attività di opzioni. La segnalazione riflette quindi una normale compensazione azionaria, non una transazione di mercato aperto, e non indica da sola una posizione direzionale sul valore di AEHR.

Resumen del Formulario 4 – Aehr Test Systems (AEHR)

El 07/02/2025, el Vicepresidente Ejecutivo Alberto Salamone informó la adquisición de 6,609 acciones comunes mediante una concesión de unidades restringidas de acciones (RSU) registrada a un costo de $0. Tras la adjudicación, su propiedad directa beneficiaria aumentó a 62,850 acciones, un total que incluye las RSU no devengadas.

La nota explicativa indica que una dieciseisava parte de las RSU se consolida cada tres meses calendario, siempre que se mantenga el empleo. No se divulgaron ventas ni transacciones con derivados, y la Tabla II no muestra actividad de opciones. Por lo tanto, la presentación refleja una compensación de acciones rutinaria, no una transacción en mercado abierto, y por sí sola no indica una visión direccional sobre la valoración de AEHR.

양식 4 개요 – Aehr Test Systems (AEHR)

2025년 2월 7일, 부사장 알베르토 살라모네가 제한 주식 단위(RSU) 부여를 통해 6,609주의 보통주를 취득하였으며, 이는 0달러 비용으로 기록되었습니다. 이 부여 후 그의 직접 실질 소유 주식 수는 62,850주로 증가했으며, 이에는 아직 권리가 확정되지 않은 RSU도 포함됩니다.

설명 노트에 따르면 RSU 부여분의 1/16이 매 3개월마다 권리가 확정되며, 고용이 유지되어야 합니다. 매도나 파생상품 거래는 없었으며, 표 II에는 옵션 활동도 나타나지 않습니다. 따라서 이 신고는 일상적인 주식 보상이며, 공개 시장 거래가 아니므로 AEHR의 가치에 대한 방향성 신호로 해석되지 않습니다.

Vue d’ensemble du Formulaire 4 – Aehr Test Systems (AEHR)

Le 07/02/2025, le vice-président exécutif Alberto Salamone a déclaré l’acquisition de 6 609 actions ordinaires via une attribution d’unités d’actions restreintes (RSU) enregistrée à un coût de 0 $. Après cette attribution, sa possession directe bénéficiaire est montée à 62 850 actions, total incluant les RSU non acquises.

La note explicative précise qu’un seizième de l’attribution de RSU acquiert un droit tous les trois mois civils, sous réserve du maintien de l’emploi. Aucune vente ni transaction dérivée n’a été divulguée, et le tableau II ne montre aucune activité d’options. Le dépôt reflète donc une rémunération en actions classique, non une transaction sur le marché ouvert, et ne signale pas à lui seul une orientation sur la valorisation d’AEHR.

Überblick zum Formular 4 – Aehr Test Systems (AEHR)

Am 07.02.2025 meldete Executive Vice President Alberto Salamone den Erwerb von 6.609 Stammaktien durch eine Zuteilung von Restricted Stock Units (RSUs), die mit 0 USD bewertet wurden. Nach der Zuteilung stieg sein direkter wirtschaftlicher Eigentumsanteil auf 62.850 Aktien, einschließlich unverfallener RSUs.

Die erläuternde Anmerkung besagt, dass ein Sechzehntel der RSU-Zuteilung alle drei Kalendermonate verfällt, vorausgesetzt, die Beschäftigung wird aufrechterhalten. Keine Verkäufe oder Derivatgeschäfte wurden offengelegt, und Tabelle II zeigt keine Optionsaktivitäten. Die Meldung spiegelt somit eine routinemäßige Aktienvergütung wider, keine Transaktion am offenen Markt, und signalisiert für sich genommen keine richtungsweisende Einschätzung der Bewertung von AEHR.

Positive
  • Executive ownership rises by 6,609 shares, bringing total direct holdings to 62,850 shares, indicating continued alignment with shareholders.
Negative
  • Shares were granted at $0 and vest over time, so the filing does not represent cash commitment or an open-market confidence signal.

Insights

TL;DR – Routine RSU grant; ownership up by 6,609 shares, minimal trading signal.

This Form 4 documents an executive compensation event rather than market buying. Because the shares were awarded at no cost and vest quarterly, instant float pressure is negligible. While a higher personal stake modestly improves alignment, the incremental 6,609 shares are small relative to the executive’s existing 62,850-share position, suggesting neutral market impact.

TL;DR – Standard equity incentive structure; neutral governance impact.

The grant follows common practice of tying management compensation to equity performance through time-based RSUs. Quarterly vesting promotes retention and long-term focus, aligning the EVP’s interests with shareholders. No unusual terms or accelerated vesting clauses are evident, so the disclosure does not raise governance concerns nor materially affect investor outlook.

Panoramica del Modulo 4 – Aehr Test Systems (AEHR)

Il 07/02/2025, il Vice Presidente Esecutivo Alberto Salamone ha comunicato l’acquisto di 6.609 azioni ordinarie tramite una concessione di unità azionarie vincolate (RSU) registrata a costo $0. Dopo l’assegnazione, la sua posizione diretta di proprietà beneficiaria è salita a 62.850 azioni, un totale che include anche le RSU non ancora maturate.

La nota esplicativa specifica che un sedicesimo delle RSU assegnate matura ogni tre mesi solari, a condizione che il rapporto di lavoro venga mantenuto. Non sono state dichiarate vendite o operazioni su derivati, e la Tabella II non evidenzia attività di opzioni. La segnalazione riflette quindi una normale compensazione azionaria, non una transazione di mercato aperto, e non indica da sola una posizione direzionale sul valore di AEHR.

Resumen del Formulario 4 – Aehr Test Systems (AEHR)

El 07/02/2025, el Vicepresidente Ejecutivo Alberto Salamone informó la adquisición de 6,609 acciones comunes mediante una concesión de unidades restringidas de acciones (RSU) registrada a un costo de $0. Tras la adjudicación, su propiedad directa beneficiaria aumentó a 62,850 acciones, un total que incluye las RSU no devengadas.

La nota explicativa indica que una dieciseisava parte de las RSU se consolida cada tres meses calendario, siempre que se mantenga el empleo. No se divulgaron ventas ni transacciones con derivados, y la Tabla II no muestra actividad de opciones. Por lo tanto, la presentación refleja una compensación de acciones rutinaria, no una transacción en mercado abierto, y por sí sola no indica una visión direccional sobre la valoración de AEHR.

양식 4 개요 – Aehr Test Systems (AEHR)

2025년 2월 7일, 부사장 알베르토 살라모네가 제한 주식 단위(RSU) 부여를 통해 6,609주의 보통주를 취득하였으며, 이는 0달러 비용으로 기록되었습니다. 이 부여 후 그의 직접 실질 소유 주식 수는 62,850주로 증가했으며, 이에는 아직 권리가 확정되지 않은 RSU도 포함됩니다.

설명 노트에 따르면 RSU 부여분의 1/16이 매 3개월마다 권리가 확정되며, 고용이 유지되어야 합니다. 매도나 파생상품 거래는 없었으며, 표 II에는 옵션 활동도 나타나지 않습니다. 따라서 이 신고는 일상적인 주식 보상이며, 공개 시장 거래가 아니므로 AEHR의 가치에 대한 방향성 신호로 해석되지 않습니다.

Vue d’ensemble du Formulaire 4 – Aehr Test Systems (AEHR)

Le 07/02/2025, le vice-président exécutif Alberto Salamone a déclaré l’acquisition de 6 609 actions ordinaires via une attribution d’unités d’actions restreintes (RSU) enregistrée à un coût de 0 $. Après cette attribution, sa possession directe bénéficiaire est montée à 62 850 actions, total incluant les RSU non acquises.

La note explicative précise qu’un seizième de l’attribution de RSU acquiert un droit tous les trois mois civils, sous réserve du maintien de l’emploi. Aucune vente ni transaction dérivée n’a été divulguée, et le tableau II ne montre aucune activité d’options. Le dépôt reflète donc une rémunération en actions classique, non une transaction sur le marché ouvert, et ne signale pas à lui seul une orientation sur la valorisation d’AEHR.

Überblick zum Formular 4 – Aehr Test Systems (AEHR)

Am 07.02.2025 meldete Executive Vice President Alberto Salamone den Erwerb von 6.609 Stammaktien durch eine Zuteilung von Restricted Stock Units (RSUs), die mit 0 USD bewertet wurden. Nach der Zuteilung stieg sein direkter wirtschaftlicher Eigentumsanteil auf 62.850 Aktien, einschließlich unverfallener RSUs.

Die erläuternde Anmerkung besagt, dass ein Sechzehntel der RSU-Zuteilung alle drei Kalendermonate verfällt, vorausgesetzt, die Beschäftigung wird aufrechterhalten. Keine Verkäufe oder Derivatgeschäfte wurden offengelegt, und Tabelle II zeigt keine Optionsaktivitäten. Die Meldung spiegelt somit eine routinemäßige Aktienvergütung wider, keine Transaktion am offenen Markt, und signalisiert für sich genommen keine richtungsweisende Einschätzung der Bewertung von AEHR.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SALAMONE ALBERTO

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, PPBI BUSINESS
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 6,609(1) A $0 62,850(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates.
2. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AEHR shares did EVP Alberto Salamone acquire on 07/02/2025?

He acquired 6,609 shares through a restricted stock unit award.

What is Alberto Salamone’s total direct beneficial ownership after the transaction?

His direct holdings increased to 62,850 shares, including unvested RSUs.

Does the Form 4 show any AEHR stock sales?

No. The filing reports an acquisition only; no sales or derivative disposals were disclosed.

What are the vesting terms of the reported RSU grant?

The RSUs vest in 1/16 increments every three months provided the executive remains employed.

Was any cash paid for the AEHR shares acquired?

No. The shares were granted at a $0 price as part of equity compensation.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

379.59M
28.11M
5.06%
72.02%
24.14%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT